GMED250117P85000
- 1.65
- 0.000.00%
Globus Medical Newsroom
Globus Medical Is Maintained at Buy by Canaccord Genuity
Jefferies Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $105
A Quick Look at Today's Ratings for Globus Medical(GMED.US), With a Forecast Between $90 to $115
Analysts Offer Insights on Healthcare Companies: Globus Medical (GMED) and Reviva Pharmaceuticals Holdings (RVPH)
Globus Medical Upgraded to Neutral From Underperform at BofA
Globus Medical Analyst Ratings
Needham Maintains Globus Medical(GMED.US) With Hold Rating
Needham Keeps Their Hold Rating on Globus Medical (GMED)
Wells Fargo Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $95
Positive Outlook and Buy Rating for Globus Medical Amid Strong Sales and Market Confidence
BTIG Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $91
BTIG Sticks to Their Buy Rating for Globus Medical (GMED)
RBC Capital Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $101
RBC Capital Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $101
Piper Sandler Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $100
Piper Sandler Reaffirms Their Buy Rating on Globus Medical (GMED)
Truist Financial Maintains Globus Medical(GMED.US) With Hold Rating, Raises Target Price to $90
RBC Raises Price Target on Globus Medical to $101 From $92, Keeps Outperform Rating
Roth MKM Maintains Globus Medical(GMED.US) With Buy Rating, Raises Target Price to $115
BTIG Maintains Globus Medical(GMED.US) With Buy Rating, Maintains Target Price $91